H.C. Wainwright Maintains Buy Rating on MoonLake Immunotherapeutics (MLXT), Keeps PT

28 5 月, 2025

One Min Read

42 Views

原文: https://finance.yahoo.com/news/h-c-wainwright-maintains-buy-193302209.html

Last Update: 28 5 月, 2025

Written By

Other Articles

Previous

H.C. Wainwright Maintains Buy Rating on Oruka (ORKA) After the Early Start of OKRA-002 Trial

Next

Loop Capital Maintains Buy Rating on Warby Parker (WRBY) Stock

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept